CSI Market
Sign In | Register

Emergent Biosolutions Inc (EBS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EBS Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Emergent Biosolutions Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent139.70
Cash & Short-term Investments139.00
Accounts receivable190.00
Other Receivables21.20
Inventories303.60
Disposal Group, Including Discontinued Operation, Assets, Current AS6.10
Other Current Assets0.00
Prepaid Expense And Other Assets Current25.40
Total Current Assets666.00
Equipment/Property/Plant Net475.10
Intangible Assets261.80
Deferred, Prepaid and Other Assets, Noncurrent7.90
Other Assets, Noncurrent0.00
Restricted Cash Current1.20
Total Assets1,116.80
Liabilities
Accounts Payable, Current AC50.20
Accrued Liabilities, Current26.20
Other Liabilities, Current42.00
Accrued Income Taxes, Current TA4.40
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities122.80
Long-term debt589.70
Total Long-term Debt589.70
Other liabilities, Noncurrent62.90
Contract With Customer Liability Current12.20
Total Liabilities775.40
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock951.80
Retained Earnings / Accumulated Deficit-333.20
Accumulated Other Comprehensive Income-6.80
Other Equity-6.80
Common Stockholder's Equity341.40
Total Stockholder's Equity341.40
Liabilities & Stockholder's Equity1,116.80
4 historic quarters locked

Sign in to unlock the full Emergent Biosolutions Inc balance sheet history.

Sign In Create Free Account

About Emergent Biosolutions Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: ebs-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001367644-26-000082

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.